Treatment of Mild-to-Moderate Acute Pain: What Can We Do to Improve the Standard of Care?

Kaiser Permanente Escondido, CA University of California School of Medicine San Diego, CA

Dr. McCarberg reports serving on the speakers' bureau for Abbott Laboratories, Alpharma Inc, Cephalon, Eli Lilly and Company, Endo Pharmaceuticals, Forest Laboratories, King, Ligand, Merck and Co, Inc, Mylan Inc, Pfizer Inc, Pricara, and Purdue Pharma LP.